James L. Freddo
Chief Tech/Sci/R&D Officer bei TRACON PHARMACEUTICALS, INC.
Profil
James L.
Freddo currently works at TRACON Pharmaceuticals, Inc., as Chief Medical Officer from 2020.
Dr. Freddo also formerly worked at Pfizer Inc., as Executive Director from 2002 to 2005, Anadys Pharmaceuticals, Inc., as Chief Medical Officer, Director & Senior VP in 2011, InfuSystem Holdings, Inc., as Director from 2008 to 2011, InfuSystem, Inc., as Director in 2011, Wyeth-Ayerst Research, as Senior Director-Oncology & Infectious Diseases from 1996 to 2002, Ignyta, Inc., as Independent Director from 2014 to 2018, Pfizer (St. Louis), as Vice President, Head-Clinical & Development Site from 2005 to 2006, and Aravive Biologics, Inc., as Chief Medical Officer & Head-Clinical Affairs.
Dr. Freddo received his undergraduate degree from Stony Brook University and doctorate degree from The University of North Carolina at Charlotte.
Aktive Positionen von James L. Freddo
| Unternehmen | Position | Beginn |
|---|---|---|
| TRACON PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01.05.2020 |
Ehemalige bekannte Positionen von James L. Freddo
| Unternehmen | Position | Ende |
|---|---|---|
| IGNYTA INC | Chief Tech/Sci/R&D Officer | 11.08.2014 |
Aravive Biologics, Inc.
 Aravive Biologics, Inc. Pharmaceuticals: MajorHealth Technology Aravive Biologics, Inc. develops novel targeted therapeutics in oncology. The company was founded by Amato Giaccia and Albert Koong and is headquartered in Houston, TX. | Chief Tech/Sci/R&D Officer | 31.05.2013 |
Anadys Pharmaceuticals, Inc.
 Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | Chief Tech/Sci/R&D Officer | 23.11.2011 |
| INFUSYSTEM HOLDINGS, INC. | Director/Board Member | 27.05.2011 |
InfuSystem, Inc.
 InfuSystem, Inc. Medical SpecialtiesHealth Technology Part of InfuSystem Holdings, Inc., InfuSystem, Inc. is a private company that manufactures external ambulatory infusion pumps. The company is based in Madison Heights, MI. InfuSystem was acquired by HAPC, Inc. from I-Flow Corp. on October 26, 2007 for $112 million. | Director/Board Member | 01.01.2011 |
Ausbildung von James L. Freddo
| Stony Brook University | Undergraduate Degree |
| The University of North Carolina at Charlotte | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| PFIZER, INC. | Health Technology |
| TRACON PHARMACEUTICALS, INC. | Health Technology |
| INFUSYSTEM HOLDINGS, INC. | Commercial Services |
| Private Unternehmen | 6 |
|---|---|
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | Health Technology |
InfuSystem, Inc.
InfuSystem, Inc. Medical SpecialtiesHealth Technology Part of InfuSystem Holdings, Inc., InfuSystem, Inc. is a private company that manufactures external ambulatory infusion pumps. The company is based in Madison Heights, MI. InfuSystem was acquired by HAPC, Inc. from I-Flow Corp. on October 26, 2007 for $112 million. | Health Technology |
Pfizer (St. Louis)
 Pfizer (St. Louis) BiotechnologyHealth Technology Part of Pfizer Inc., Pfizer (St. Louis) is a private company that provides research services in prescription medicines for humans and animals. The company is based in Chesterfield, MO. | Health Technology |
| Wyeth-Ayerst Research | |
Aravive Biologics, Inc.
Aravive Biologics, Inc. Pharmaceuticals: MajorHealth Technology Aravive Biologics, Inc. develops novel targeted therapeutics in oncology. The company was founded by Amato Giaccia and Albert Koong and is headquartered in Houston, TX. | Health Technology |
Ignyta, Inc.
 Ignyta, Inc. BiotechnologyHealth Technology Ignyta, Inc. operates as a medicine biotechnology company. The firm engages in the discovering, acquiring, developing and commercializing targeted new drugs for cancer patients. The company was founded by Jonathan E. Lim on September 13, 2011 and is headquartered in South San Francisco, CA. | Health Technology |
